Hongshan Chen

2.9k citations
60 papers · 1.8k indexed · 1 hit paper · h-index 24
Topics
RNA modifications and cancer (6 papers)Epigenetics and DNA Methylation (5 papers)interferon and immune responses (4 papers)

In The Last Decade

Hongshan Chen

58 papers receiving 1.8k citations

Hit Papers

TRAP1 drives smooth muscle cell senescence and promotes a...2024202620252024204060

Peers

Hongshan Chen
Comparison fields: 5 of 117
  • Molecular Biology 1.0k
  • Immunology 336
  • Cancer Research 248
  • Physiology 207
  • Epidemiology 205
Replace Aya Naiki‐Ito with:
Aya Naiki‐Ito Japan
Eduardo Cremonese Filippi‐Chiela Brazil
Weitao Cong China
Eric Ciamporcero Italy
Ganggang Shi China
Francesca Scrimieri United States
Lihong Chen China
Miran Jang South Korea
Si Chen China
Hongshan Chen relative to Aya Naiki‐Ito Japan Aya Naiki‐Ito's profile →
Citations per field
00.5×
Aya Naiki‐Ito · 1×
Citations per year

Countries citing papers authored by Hongshan Chen

Since Specialization
Citations

This map shows the geographic impact of Hongshan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongshan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongshan Chen more than expected).

Fields of papers citing papers by Hongshan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongshan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongshan Chen. The network helps show where Hongshan Chen may publish in the future.

Co-authorship network of co-authors of Hongshan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Hongshan Chen. A scholar is included among the top collaborators of Hongshan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongshan Chen. Hongshan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 10
4 10
5 45
6 2
7 14
8 8
9 15
10 44
11 61
12 91
13 25
14 15
15 11
16 26
17 92
18 19
19 12
20 8

About Hongshan Chen

Hongshan Chen is a scholar working on Cancer Research, Hepatology and Molecular Biology, having authored 60 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (5 papers) and interferon and immune responses (4 papers). The work is most often cited by research in Cancer Research (248 citations), Immunology (336 citations) and Molecular Biology (1.0k citations). Hongshan Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Matthew J. Gamble, Penelope D. Ruiz, Wendy M. McKimpson, Richard N. Kitsis, Hong Jiang, Quanwen Yin, Jong Woo Park, J. Jessica Yu, B. Belinda Ding and Enguang Bi. Their work appears in journals such as Advanced Materials, Circulation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026